| Ytd | 106.36% | |
| 1y | -44.85% |
| Open | 4.60 | Prev Close | 4.64 | Low | 4.55 | High | 4.91 | Mkt Cap | 471.04M |
| Vol | 1.87M | Avg Vol | 1.50M | EPS | -0.75 | P/E | N/A | Forward P/E | -3.42 |
| Beta | 1.19 | Short Ratio | 3.16 | Inst. Own | 64.24% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 4.46 | 200-d Avg | 3.75 | 1yr Est | 13.00 |
Rezolute, Inc. (NASDAQ: RZLT - Get Free Report) has been assigned an average recommendation of "Mode
Analysts upgraded NetApp, Humana, Corteva, Afya, with price-target changes for four stocks.
Lake Street analyst Daniel Brims maintains Rezolute (NASDAQ:RZLT) with a Buy and raises the price
Citizens analyst Jason N. Butler maintains Rezolute (NASDAQ:RZLT) with a Market Outperform and ra
Analysts upgraded Boyd Gaming, NeoGenomics, PENN Entertainment, XP and Rezolute, raising targets for
Rezolute (NASDAQ: RZLT) shares surged after the FDA recommended a pre-BLA meeting for its congenital
Rezolute, Inc. (NASDAQ: RZLT - Get Free Report) was the recipient of some unusual options trading ac
The Agency reiterated its commitment to addressing the unmet need for treatment of congenital and tu
The Agency reiterated its commitment to addressing the unmet need for treatment of congenital and tu
Vicor shares surged 12% after raising Q3 growth guidance above 30%; Roze AI led gainers, while Corte
Lake Street analyst Daniel Brims initiates coverage on Rezolute (NASDAQ:RZLT) with a Buy rating a
Analysts upgraded STAA, NFLX, SFIX, with ratings moving toward Buy or Neutral and mixed price-target
Craig-Hallum analyst Albert Lowe upgrades Rezolute (NASDAQ:RZLT) from Hold to Buy and raises the
U.S. stocks rose as oil fell on Strait of Hormuz hopes; Benzinga highlights top analysts’ picks: OKT
HC Wainwright & Co. analyst Douglas Tsao maintains Rezolute (NASDAQ:RZLT) with a Buy and rais
Rezolute (NASDAQ:RZLT) reported quarterly losses of $(0.20) per share which missed the analyst conse
REDWOOD CITY, Calif., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” o
Shares of Rezolute, Inc. (NASDAQ: RZLT - Get Free Report) have earned a consensus recommendation of
Data from the Phase 3 sunRIZE study remains under review by FDA The OLE Phase of the study is ongoin
Data from the Phase 3 sunRIZE study remains under review by FDA The OLE Phase of the study is ongoi
REDWOOD CITY, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” o
Bank of America Corp DE reduced its stake in Rezolute, Inc. (NASDAQ: RZLT) by 31.3% during the undef
Dow Jones index gained around 350 points on Friday. MARA Holdings Inc (NASDAQ: MARA) rose sharply, w
REDWOOD CITY, Calif., July 21, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or
Presentations included analyses of natural history and adverse outcomes in congenital hyperinsulinis
Rezolute rises 38% in a week after interim upLIFT data shows most tumor HI patients cut or eliminate
REDWOOD CITY, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or
Dow falls 296 points. Navitas Semi rises on partnership with Nvidia. Other gainers: ABVX, MMED, KELY
U.S. stock futures surged on Wed. as Nasdaq futures rose over 7%, driven by AI. Marvell's stock
Rezolute, Inc. (NASDAQ:RZLT) reported an interim update from its ongoing Phase 3 upLIFT study evalua
Study now 50% enrolled 6 of 8 participants have already met the responder criterion for the study's
REDWOOD CITY, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or
REDWOOD CITY, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or
Includes results from additional continuous glucose monitoring (CGM)-based outcomes which demonstrat
LOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Rezolute, Inc., (“Rezol
Oral presentation will include previously announced topline results as well as pre-specified and pos
RZLT stock jumps 12% after an FDA meeting highlights ersodetug data and next steps, despite an earli
On Wednesday, 311 stocks hit new 52-week lows.
On Monday, 369 companies set new 52-week lows.
During Friday, 125 stocks hit new 52-week lows.
On Thursday, 111 stocks hit new 52-week lows.